Protein-energy malnutrition. Unspecified severe protein-energy malnutrition
Conditions
Interventions
Treatment - Drugs
Intervention 1: control group:high protein diet daily through Mifflin - Benedict is calculated and two vials of albumin placebo. Intervention 2: Intervention group: intravenous administration of human
control group:high protein diet daily through Mifflin - Benedict is calculated and two vials of albumin placebo.
Intervention group: intravenous administration of human albumin 20% of physicians daily 2 vials Shhr Darou company received a normal diet under standard formula for calculating the Harris - Benedict a
Sponsors
Yazd Shahid Sadoughi University of Medical Science
Eligibility
Sex/Gender
All
Age
20 Years to 85 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: adult patients; serum albumin less than 5/3 g per deciliter; have the power and volume of gastric antral support at least 200 cc every 3 hours; a minimum of 24 hours of ICU stay and not take part in another trial research. Exclusion criteria: patients with feeding intolerance antral; antral power outages up to 48 hours; patients with kidney disease; liver disease and any underlying medical condition that is associated with protein loss are excluded. Patients who change the way they eat or be transferred to other centers throughout the city are also excluded.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prealbummin. Timepoint: weekly. Method of measurement: blood sample. mg/dl.;Serum albumin. Timepoint: weekly. Method of measurement: blood sample. mg/dl. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShima Dehghan
Yazd Shahid Sadoughi University of Medical Science
Outcome results
None listed